期刊文献+

靶向VEGFR2基因的siRNA分子血清稳定性及其基因沉默效应 被引量:3

Construction of small interfering RNA targeting mouse vascular endothelial growth factor receptor-2:its serum stability and gene silencing efficiency in vitro
下载PDF
导出
摘要 目的设计并合成抗小鼠VEGFR2基因的siRNA分子(siVEGFR2),研究其血清稳定性和基因沉默效应,以便进一步研究经组织靶向性结构修饰后该siRNA分子的特性。方法设计并合成抗小鼠VEGFR2基因的siRNA分子,在37℃条件下与新鲜血清共孵育24h,不同时间点后取样电泳观察其完整性;用脂质体介导转染体外培养的MS1细胞,通过半定量RT-PCR分析基因沉默效果。结果随着孵育时间延长,未经修饰的siVEGFR2分子在血清中逐渐降解;经siVEGFR2转染的MS1细胞中,VEGFR2mRNA的表达水平明显下降,与空白转染组和对照siRNA转染组相比有显著差异(P<0.001),而空白转染组和对照siRNA转染组间比较无显著性差异(P=0.157)。结论裸siVEGFR2分子在血清中容易降解,siVEGFR2能特异性沉默靶基因的表达,为下一步体内应用siVEGFR2分子时稳定性修饰的必要性提供了理论依据。 Objective To construct a small interfering RNA (siRNA) targeting mouse vascular endothelial growth factor receptor-2 (VEGFR2) and study its serum stability and gene silencing efficiency in vitro. Methods The synthesized siRNA targeting VEGFR2 (siVEGFR2) diluted in RNase-free water was mixed at a 1:1 ratio with fresh serum and incubated at 37 ℃. Gel electrophoresis was performed to determine the integrity of siVEGFR2 incubated for different time lengths. Oligofectamine 2000 was used to mediate siVEGFR2 transfection of MS 1 cells, and semi,quantitative RT-PCR was used to evaluate VEGFR2 gene silencing effect induced by the siRNA. Results The naked siRNA incubated in serum underwent gradual degradation with prolonged incubation time and became virtually undetectable after 24 h. Transfection of MS 1 cells with siVEGFR2 significantly down-regulated the expression of VEGFR2 mRNA in comparison with the blank group and control siRNA transfection group (P〈0.001), while no significant difference was found in VEGFR2 mRNA levels between the latter two groups (P=-0.157). Conclusion The naked siRNA is unstable in serum and not suitable for direct administration in vivo. The designed siRNA can effectively silence the VEGFR2 gene expression in MSI cells in vitro.
作者 曹波 季爱民
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第5期864-867,共4页 Journal of Southern Medical University
基金 国家自然科学基金(30672557) 广东省自然科学基金重点项目(8251051501000008)
关键词 SIRNA 血管内皮生长因子受体2 血清稳定性 基因沉默 small interfering RNA vascular endothelial.growth factor receptor-2 serum stability gene silencing
  • 相关文献

参考文献5

二级参考文献42

共引文献72

同被引文献21

  • 1Ferre P, Foufelle F. SREBP-lc transcription factor and lipid homeostasis; Clinical perspective[J]. Horm Res, 2007,68:72-82.
  • 2Tiang J M,Butcher N J,Cullinane C,et al. RNAi-medi- ated knock-down of arylamine nacetyltransferase-1 expression inducese-cadherin up-regulation and cell-cell contact growth inhibition [J]. PLoS one, 2011,6 (2) : e17031.
  • 3Gao X, Zhang P. Transgenic RNA interference in mice [J]. Physiolagy, 2007,22 : 161-166.
  • 4Horton J D,Goldstein J L,Brown M S. SREBPs:acti- vators of the complet program of cholesterol and fatty acid synthesis in the liver[J]. J Clin Invest, 2002,109: 1125-1131.
  • 5Foretz M,Guichard C, Ferre P, et al. Sterol regulatory element binding protein-lc is a major mediator of ins, ulin action on the hepatic expression of glucokinase and lipogenesis-related genes [J]. Proe Natl Aead Sci USA, 1999,96 : 12737-12742.
  • 6Bobard H, Hainault I, Ferre P, et al. Differential regu- lation of SREBP-lc transcriptional activity by insulin and LXR during liver development[M]. [S. I. ]: JBC- Papers in Press, 2004.
  • 7Osborne T F. Sterol regulatory element-bindingprotei ns:key regulatorsof nut-ritional Homeostasis and insu- lin action[J]. J Biol Chem, 2000,275 : 32379-32382.
  • 8Takakura Y. Towards therapeutic application of RNA- mediated gene regulation [J]. Adv Drug Deliv Rev, 2009,61 (9) : 667.
  • 9Castanotto D, Rossi J J. The promises and pitfalls of RNA-interference-based therapeutics [J]. Nature, 2009,457(7228) :426- 433.
  • 10Fire A, Xu S, Montgomery M K, et al. Potent and spe_ cific genetic interference by double-stranded RNA in Caenorhabditis elegans [J]. Nature, 1998, 391 : 806- 811.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部